|
|
||||||||
Ann Thorac Surg 2006;81:892-895
© 2006 The Society of Thoracic Surgeons
a Department of Cardiothoracic Surgery, Medical University Vienna, Vienna, Austria
b Department of Vascular Surgery, Medical University Vienna, Vienna, Austria
c Department of Clinical Pharmacology, Medical University Vienna, Vienna, Austria
Accepted for publication September 26, 2005.
* Address correspondence to Dr Zimpfer, Department of Cardiothoracic Surgery, Medical University Vienna, Wahringer Guertel 18-20, A-1090 Vienna, Austria (Email: daniel.zimpfer{at}meduniwien.ac.at).
BACKGROUND: Extracorporeal membrane oxygenation support through the groin vessels is an established treatment option for patients with life-threatening conditions, resistant to medical treatment. However, because of critical status and type of vascular access, late vascular complications are a potential risk.
METHODS: From January 1998 through December 2004, 174 adults (mean age, 45 ± 19 years) undergoing either cardiac surgery (n = 54, 31.4%) or lung transplantation (n = 120, 68.6%) were supported with extracorporeal membrane oxygenation. Data were prospectively collected and retrospectively analyzed. Follow-up extended up to 60 months (mean, 30 ± 10 months). Multivariable regression analysis was used to identify predictors of late vascular complications.
RESULTS: Hospital survival was 57.3%. A total of 12 hospital survivors (12.2%) experienced late vascular complications. All late vascular complications were local stenosis at the former arterial cannulation site. Treatment was done by means of femorofemoral crossover bypass (n = 3), iliofemoral bypass (n = 1), thromboendarterectomy (n = 3), and percutaneous transluminal angioplasty (n = 5). We experienced no limb loss during follow-up. Predictors for long-term vascular complications were technical problems during extracorporeal membrane oxygenation explantation (p = 0.002; odds ratio, 23.2) and history of peripheral vascular disease (p = 0.015; odds ratio, 3.1).
CONCLUSIONS: Extracorporal membrane oxygenation support is associated with the development of late vascular complications at the femoral access site. In selected patients alternative cannulation sites should be considered.
This article has been cited by other articles:
![]() |
F. Bakhtiary, H. Keller, S. Dogan, O. Dzemali, F. Oezaslan, D. Meininger, H. Ackermann, B. Zwissler, P. Kleine, and A. Moritz Venoarterial extracorporeal membrane oxygenation for treatment of cardiogenic shock: clinical experiences in 45 adult patients. J. Thorac. Cardiovasc. Surg., February 1, 2008; 135(2): 382 - 388. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Dexter, G. P. Cosgrove, and I. S. Douglas Managing a Rare Condition Presenting With Intractable Hypoxemic Respiratory Failure Chest, January 1, 2007; 131(1): 320 - 327. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |